Shanghai issued a message, collect drugs for 30 days to pay back!

Recently, Shanghai Sunshine Procurement Network issued a notice that it is expected to formally implement the third batch of drugs in mid-to-late November.
, the Notice also requires that the use of medical institutions in principle is not lower than the level of the same period last year.
medical institutions may choose to use other drugs with the same generic name and efficacy as suitable prices for the Shanghai Internet, medical institutions may choose to use them under the premise of priority procurement of the selected drugs.
, it is even more noteworthy that, according to the requirements of the Shanghai Pharmaceutical Centralized Tendering and Procurement Service Management Institute, medical institutions shall purchase the selected drugs through the pharmaceutical operation or distribution enterprise designated by the selected enterprise, and the repayment time shall not exceed 30 days.
industry believes that this provision will be too slow to pay back medical institutions to protect enterprises, greatly reducing the burden of pharmaceutical institutions, including the pressure of capital flow.
it is understood that the arrears of drug payments, has been the field of medicine, a "big problem."
In September 2018, the Hubei Pharmaceutical Industry Association, which surveyed eight representative pharmaceutical commercial enterprises, showed that there were public medical institutions with a back payment period of 960 days, 32 times the amount of 30 days of payment required by the state, and a amount of 86 million yuan in arrears.
addition, there is a provincial district of the average account period of public hospitals at level 2 and above are about 640 days, a total of arrears of a commercial company drug payments of up to 280 million yuan.
even have a repayment period of up to 60 months, that is, five years.
return cycle, the greater the risk to drug companies.
years, there are many drug dealers due to the problem of withdrawal of funds, can not continue to operate, take the initiative to revoke the GSP certificate, tearful farewell to drug management.
, the arrears of medical institutions will undoubtedly restrict the cash flow of the pharmaceutical industry to a certain extent.
and this time Shanghai clearly the third batch of collection of medical institutions within 30 days of repayment, but also of course by the industry as another industry good.
problem of defaulting on the loans of pharmaceutical enterprises in public hospitals has a long history.
, the state has also been introducing relevant policies to the medical institutions to pay back the problem of slow rectification.
If, in December 2019, the Ministry of Industry and Information Technology issued the Opinions on the Measures for the Administration of Timely Payment of SmEs (Draft for Comments), which clearly requires that large enterprises abuse their dominant position in the market to force SMEs to accept unreasonable payment terms or delay the payment of SME payments, they will be ordered by the market supervision and administration department to make corrections and fined between 100,000 yuan and 500,000 yuan.
March 2020, the Opinions on Deepening the Reform of the Medical Security System clearly stated that "promoting the direct settlement of medical insurance funds with pharmaceutical enterprises" provides a basic follow-up to solve the problem of medical institutions defaulting on drug payments.
The State Health Insurance Administration pointed out that "guaranteed timely repayment" is an important factor to reduce the cost of enterprises, thereby reducing drug prices, all departments attach great importance to the formulation and implementation of a series of policy measures.
May, the State Health Insurance Administration issued a Notice on the Issue of the National List of Government Services for the Administration of Medical Security, specifying that the time limit for the settlement of expenses of designated medical institutions (including medical institutions and retail pharmacies) shall not exceed 30 working days.
According to the deployment, by the end of August 2020, the provincial medical security departments should earnestly follow the content and format requirements of the national list, complete the publication of the provincial list and guidelines, synchronize and standardize the processing of matters on the line (including mobile terminals), and ensure the formal implementation of the inventory system by the end of August 2020.
addition to the date of repayment, the National Health Insurance Administration is further promoting the direct settlement or advance payment of medicines by health insurance agencies or procurement agencies and enterprises.
that the current Zhejiang, Gansu, Jiangsu, Fujian and other provinces of the health insurance funds are trying to directly settle the purchase price to enterprises.
view, the various provincial procurement platforms are functioning well, solving the triangular debt of enterprises, hospitals and circulation links, and achieving a win-win situation for all parties.
In addition, from the "4 plus 7" pilot actual operation, "4 plus 7" pilot products selected 30 days clearance rate reached more than 90%, but also fully shows that the problem of medical institutions defaulting on drug payments is being effectively alleviated.
can say that, all along, some pharmaceutical companies and drug dealers by the hospital arrears of payment is really suffering.
but as health care reform continues to deepen, more and more changes are taking place in the industry.
future, with the gradual promotion and implementation of 30 days in the country, in addition to the standardization of public hospital management will have a far-reaching impact, but also will promote the entire pharmaceutical circulation industry reshuffle.